Effect of Melatonin in side effects of second-generation antipsychotic medications

Phase 2

• Conditions: Condition 1: schizophrenia. Condition 2: bipolar disorder.; Schizophrenia; Bipolar affective disorder

• Registration Number: IRCT2016051027832N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

men and women 18 to 64 years old who have recently been treated with second-generation antipsychotics; Exclusion criteria: patients with high blood pressure, diabetes, lipid disorders, thyroid disorders and liver diseases; a history of sensitivity to melatonin; high risk of suicide or aggression; pregnant women or lactating; patients at any time during the study drugs antipsychotic abandoned or Do not take two doses of melatonin pill; substance Abuse or dependence in the last 6 months;

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified